Recorded Chinese product: 利巴韦林葡萄糖注射液利巴韦林葡萄糖注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
No product-level labeled indications/safety are joined for this record.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京康乃克药业公司Chinese legal name: 北京康乃克药业公司
主要成分Active Ingredients
- 利巴韦林Liba Weilin
- 葡萄糖Putao Tang
药物知识说明
利巴韦林是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括:利巴韦林Liba Weilin、葡萄糖Putao Tang。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品:利巴韦林-e1136c4c成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 利巴韦林葡萄糖注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 利巴韦林Liba Weilin, 葡萄糖Putao Tang.
Explore other medicines containing the same ingredient: 利巴韦林 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 利巴韦林葡萄糖注射液Recorded Chinese product: 利巴韦林葡萄糖注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 玻璃输液瓶装,250ml:利巴韦林0.5g与葡萄糖12.5g。Recorded Chinese description: 玻璃输液瓶装,250ml:利巴韦林0.5g与葡萄糖12.5g。
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 黑龙江福和华星制药集团股份有限公司Chinese legal name: 黑龙江福和华星制药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20043723
- 哈希页恢复注册号(来源 Phase 31.2B / extended_via_reg)Registration recovered for hash slug (Phase 31.2B / extended_via_reg)
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.